Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name ANTERIOS INC Proposed Ticker ANTE CUSIP 03675F104 Business Description A clinical stage biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum products for therapeutic and aesthetic applications. Lead Underwriter RBC Capital Markets, LLC, Stifel Nicolaus & Company, Incorporated Co-Managers JMP Securities LLC, Needham & Company, LLC Initial Shares 3,900,000 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.